Saltar a la navegació principal
Saltar a la cerca
Vés al contingut principal
Ordenar per
Keyphrases
Human Immunodeficiency Virus Type 1 (HIV-1)
100%
Virological Failure
100%
Multidrug-resistant
100%
CD4 Count
100%
Experienced Patients
100%
Antiretroviral-experienced
100%
Fitness Evolution
100%
Monotherapy
66%
Recombinant Virus
66%
Antiretroviral Therapy
66%
Viral Fitness
66%
Replicative Capacity
66%
Resistant mutation
66%
In(III)
33%
Plasma Samples
33%
Treatment Strategy
33%
Virus
33%
Protease
33%
Protease Inhibitors
33%
Coding Region
33%
Active Substances
33%
Infectivity
33%
Viral Production
33%
Infected Patients
33%
Clinical Practice Guidelines
33%
Treatment Results
33%
Reverse Transcriptase
33%
Reverse Transcriptase Inhibitors
33%
Human Immunodeficiency Virus Infection
33%
Combination Regimen
33%
Long-term Antiretroviral Therapy
33%
Infectious Diseases Society of America
33%
Infectivity Assay
33%
Detectable Viral Load
33%
Kinetic Data
33%
3' End
33%
Drug Susceptibility
33%
Resistant Virus
33%
Medicine and Dentistry
Infection
100%
Human Immunodeficiency Virus 1
100%
Monotherapy
100%
Genetic Transfection
100%
Cell Count
100%
Virus Recombinant
100%
Virus
100%
T-Helper Cell
100%
Proteinase
50%
Antiretroviral Therapy
50%
Proteinase Inhibitor
50%
Reverse-Transcriptase Inhibitor
50%
Drug Sensitivity
50%
Human Immunodeficiency Virus Infection
50%
Infectious Disease
50%
Reverse Transcriptase
50%
Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Recombinant Virus
100%
Virus
100%
Genetic Transfection
100%
CD4 Lymphocyte Count
100%
Reverse Transcriptase
100%
Infection
100%
Viral Load
50%
Blood Plasma
50%
Human Immunodeficiency Virus Infection
50%
Wild Type
50%
Drug Sensitivity
50%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Human Immunodeficiency Virus 1
100%
Monotherapy
100%
Proteinase
50%
Proteinase Inhibitor
50%
Human Immunodeficiency Virus Infection
50%
RNA Directed DNA Polymerase Inhibitor
50%
Diseases
50%
Reverse Transcriptase
50%